Exelixis
EXEL
#1772
Rank
ยฃ8.80 B
Marketcap
ยฃ32.72
Share price
0.05%
Change (1 day)
13.13%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company